Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332124 · ClinicalTrials.gov registry record · Phase 1
Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
A Phase 1 study of Pregnancy and Child Development, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 351
- Enrollment target
- 1
- Study location
NCT00332124 is a Phase 1 study of Pregnancy and Child Development that has completed, run by University of Colorado, Denver. The registered enrollment target is 351 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00332124, a Phase 1 study of Pregnancy and Child Development, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 351 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the safety and effectiveness of taking choline supplements during pregnancy, and whether choline supplementation has an effect on infant development.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DRUG Choline
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2006-06 |
| Est. Completion | 2017-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332124
The ClinicalTrials.gov registry entry for NCT00332124 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 351 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (60% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00332124 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT00332124 about?
NCT00332124 is a clinical study titled "Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development". This study will evaluate the safety and effectiveness of taking choline supplements during pregnancy, and whether choline supplementation has an effect on infant development.
What is the current status of trial NCT00332124?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 351 participants. The study started on 2006-06. Estimated completion is 2017-03.
What conditions does trial NCT00332124 study?
This clinical trial studies the following conditions: Pregnancy, Child Development.
What interventions are being tested in trial NCT00332124?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Choline (DRUG).
Who is sponsoring clinical trial NCT00332124?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00332124 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Parents Matter!: Interventions to Promote Effective Parent-Child Communication
COMPLETED · Phase 1
-
A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
COMPLETED · Phase 1
-
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
COMPLETED · Phase 1
-
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood
COMPLETED · Phase 1
-
A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
COMPLETED · Phase 1
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.